Arteriosclerosis obliterans

Preview

With improvement in noninvasive assessment methods in recent years, therapeutic options for arteriosclerosis obliterans have expanded. Much can be done to control symptoms of intermittent claudication and improve overall functioning before angioplasty or bypass surgery need be considered. Here Drs Ku and Nagler discuss the options in evaluation and management of this costly medicosocial problem.

Additional information

Notes on contributors

Aubrey Ku

Aubrey Ku, MD Willibald Nagler, MD Dr Ku (right) is chief resident, New York Hospital-Cornell Medical Center, and Dr Nagler (left) is professor and chairman, department of physical medicine and rehabilitation, Cornell University Medical College, New York.

Willibald Nagler

Aubrey Ku, MD Willibald Nagler, MD Dr Ku (right) is chief resident, New York Hospital-Cornell Medical Center, and Dr Nagler (left) is professor and chairman, department of physical medicine and rehabilitation, Cornell University Medical College, New York.